207 related articles for article (PubMed ID: 12748304)
1. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.
Okouneva T; Hill BT; Wilson L; Jordan MA
Mol Cancer Ther; 2003 May; 2(5):427-36. PubMed ID: 12748304
[TBL] [Abstract][Full Text] [Related]
2. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
Kelling J; Sullivan K; Wilson L; Jordan MA
Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.
Ngan VK; Bellman K; Hill BT; Wilson L; Jordan MA
Mol Pharmacol; 2001 Jul; 60(1):225-32. PubMed ID: 11408618
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase.
Okouneva T; Azarenko O; Wilson L; Littlefield BA; Jordan MA
Mol Cancer Ther; 2008 Jul; 7(7):2003-11. PubMed ID: 18645010
[TBL] [Abstract][Full Text] [Related]
5. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
7. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
8. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis.
Jordan MA; Thrower D; Wilson L
J Cell Sci; 1992 Jul; 102 ( Pt 3)():401-16. PubMed ID: 1506423
[TBL] [Abstract][Full Text] [Related]
9. Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway.
Pourroy B; Carré M; Honoré S; Bourgarel-Rey V; Kruczynski A; Briand C; Braguer D
Mol Pharmacol; 2004 Sep; 66(3):580-91. PubMed ID: 15322250
[TBL] [Abstract][Full Text] [Related]
10. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
11. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
12. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
13. Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers.
Hill BT
Curr Pharm Des; 2001 Sep; 7(13):1199-212. PubMed ID: 11472262
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine in cancer therapy.
Capasso A
Curr Drug Targets; 2012 Jul; 13(8):1065-71. PubMed ID: 22594474
[TBL] [Abstract][Full Text] [Related]
15. Mitotic arrest and anaphase aberrations induced by vinorelbine in hamster cells in vitro.
González-Cid M; Cuello MT; Larripa I
Anticancer Drugs; 1997 Jun; 8(5):529-32. PubMed ID: 9215618
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.
Pourroy B; Honoré S; Pasquier E; Bourgarel-Rey V; Kruczynski A; Briand C; Braguer D
Cancer Res; 2006 Mar; 66(6):3256-63. PubMed ID: 16540678
[TBL] [Abstract][Full Text] [Related]
17. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
[TBL] [Abstract][Full Text] [Related]
18. Mitotic block in HeLa cells by vinblastine: ultrastructural changes in kinetochore-microtubule attachment and in centrosomes.
Wendell KL; Wilson L; Jordan MA
J Cell Sci; 1993 Feb; 104 ( Pt 2)():261-74. PubMed ID: 8505360
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes.
González-Cid M; Cuello MT; Larripa I
Mutagenesis; 1999 Jan; 14(1):63-6. PubMed ID: 10474823
[TBL] [Abstract][Full Text] [Related]
20. The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively.
Klotz DM; Nelson SA; Kroboth K; Newton IP; Radulescu S; Ridgway RA; Sansom OJ; Appleton PL; Näthke IS
J Cell Sci; 2012 Feb; 125(Pt 4):887-95. PubMed ID: 22399804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
